tiprankstipranks
Trending News
More News >
Palisade Bio (PALI)
NASDAQ:PALI
US Market

Palisade Bio (PALI) Technical Analysis

Compare
530 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Neutral
2Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Palisade Bio’s (PALI) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Palisade Bio is a Sell.
Palisade Bio’s (PALI) 20-Day exponential moving average is 0.69, while Palisade Bio’s (PALI) share price is $0.74, making it a Buy.
Palisade Bio’s (PALI) 50-Day exponential moving average is 0.74, while Palisade Bio’s (PALI) share price is $0.74, making it a Sell.

Palisade Bio (PALI) Pivot Points

Jun 25, 2025, 07:50 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.51
0.57
0.63
0.69
0.75
0.81
0.87
Fibonacci
0.57
0.61
0.64
0.69
0.73
0.76
0.81
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Palisade Bio (PALI) Moving Averages

Jun 25, 2025, 07:50 PM
Period
Simple
Exponential
MA5
0.67Buy
0.69Buy
MA10
0.66Buy
0.68Buy
MA20
0.70Buy
0.69Buy
MA50
0.72Buy
0.74Sell
MA100
0.81Sell
0.99Sell
MA200
1.73Sell
1.83Sell
Palisade Bio’s (PALI) 10-Day exponential moving average is 0.68, while Palisade Bio’s (PALI) share price is $0.74, making it a Buy.
Palisade Bio’s (PALI) 100-Day exponential moving average is 0.99, while Palisade Bio’s (PALI) share price is $0.74, making it a Sell.
Palisade Bio’s (PALI) stock price is $0.74 and Palisade Bio’s (PALI) 50-day simple moving average is 0.72, creating a Buy signal.
Palisade Bio’s (PALI) stock price is $0.74 and Palisade Bio’s (PALI) 100-day simple moving average is 0.81, creating a Sell signal.
Palisade Bio’s (PALI) stock price is $0.74 and Palisade Bio’s (PALI) 200-day simple moving average is 1.73, creating a Sell signal.

Palisade Bio (PALI) Technical Indicators

Jun 25, 2025, 07:50 PM
Name
Value
Implied Action
RSI (14)
55.23
Neutral
STOCH (9,6)
58.17
Neutral
STOCHRSI (14)
53.29
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
13.24
Buy
Williams %R
-12.50
Sell
CCI (14)
43.02
Neutral
ATR (14)
0.06
-
Ultimate Oscillator
46.07
Neutral
ROC
0.00
Sell
Palisade Bio’s (PALI) Relative Strength Index (RSI) is 55.23, creating a Neutral signal.
Palisade Bio’s (PALI) Trend Strength Indicator (ADX) is 13.24, creating a Buy signal.
Palisade Bio’s (PALI) Commodity Channel Index (CCI) is 43.02, creating a Neutral signal.

FAQ

Is PALI a Buy, Hold, or Sell?
Based on PALI’s technical indicators, PALI is a Hold.
    What is PALI’s RSI (14)?
    PALI’s RSI (14) is 55.23, which suggests PALI is a Neutral.
      What is PALI’s MACD?
      PALI’s MACD is -0.02, which suggests PALI is a Sell.
        What is PALI’s 5-day moving average?
        PALI’s 5-day moving average is 0.67, which suggests PALI is a Buy.
          What is PALI’s 20-day moving average?
          PALI 20-day moving average is 0.70, which suggests PALI is a Buy.
            What is PALI’s 50-day moving average?
            PALI’s 50-day moving average is 0.72, which suggests PALI is a Buy.
              What is PALI’s 200-day moving average?
              PALI’s 200-day moving average is 1.73, which suggests PALI is a Sell.
                What is PALI’s Williams % R (14)?
                PALI’s Williams % R (14) is -12.50, which suggests PALI is a Sell.
                  What is PALI’s CCI (14)?
                  PALI’s CCI (14) is 43.02, which suggests PALI is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis